CVC in Running for Turkish Drug Maker Bilim
London-based private equity firm CVC Capital Partners, European buyout firm Cinven and London-based Advent Venture Partners are all in the running for a stake in Turkish drug maker Bilim Ilac, Reuters said. The size of the potential deal is unclear.




